Progenics, Inc.

New York, NY 10036

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $0.0
First Award Date 03/01/85
Most Recent Award Date 05/01/87

Key Personnel

Last Name Name Awards Contact
Applezweig Norman Applezweig 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/87 - 04/30/88

The evaluation of 3-alpha and 3-beta etiocholanolones as hematopoietic agents in the management of patients with aplastic anemia may now be undertaken because of the availability of both epimers prepared by economical synthetic methods. This research plan proposes both acute and short term toxicological and pharmacodynamic studies on etiocholan...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/86 - 04/30/87

The evaluation of 3-alpha and 3-beta etiocholanolones as hematopoietic agents in the management of patients with aplastic anemia may now be undertaken because of the availability of both epimers prepared by economical synthetic methods. This research plan proposes both acute and short term toxicological and pharmacodynamic studies on etiocholan...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/85 - 08/31/85

The use of Alpha-etiocholanolone and Beta-etiocholanolone in aplastic anemia shows promise, but the supply is very limited due to the lack of a good synthesis from readily available material. Beta-etiocholanolone would be less traumatic to the patient, but is not readily available again for the above mentioned reason. The focus for Phase I wou...